Clover Health Investments Corp (CLOV)
$2.83
0.04 (1.25%)
CLOV Stock Quote Delayed 30 Minutes
Clover Health’s Earnings Losses Make It One to Avoid for Now
CLOV stock should not be bought until it has positive earnings. The company has good growth to report but needs earnings to lower the risk.
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
3.12M
Day's Range
$2.65 - $2.88
52-Week Range
$1.95 - $28.85
Dividend & Yield
N/A (N/A)
CLOV Stock Predictions, Articles, and Clover Health Investments Corp News
Has Clover Health Finally Bottomed Out?
Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock.
Clover Health’s Technology Is Great But With Dead Money
Clover Health has interesting technology, but unless it can end losses this year it may not have a 2023. It has great technology but may lack the financial strength to make it in the Medicare Advantage arena.
It’s Time for Clover Health to Think Outside the Box
A possible revenue stream for Clover Health is their policyholder’s health data. Could that be a way to get CLOV stock out of its funk?
The Clover Health Debate Will Likely Settle With a Bullish Victory
The Clover Health debate is a fiery one and it won't settle except in hindsight. Meanwhile, the better opportunity in CLOV stock is upside.
Clover Health Stock Is No Longer a Meme Stock
A lack of battleground interest and and Clover Health's improving business bode well for long-term CLOV stock investors.
Don’t Buy CLOV Stock Ahead of Earnings Report
CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings.
Clover Health Stock May Rise As Millions Could Lose Health Coverage
CLOV stock has been under heavy selling pressure, but brighter days should lie ahead as Clover Health offers insure-tech solutions.
Do Not Think of Clover Stock as a Bargain Yet
Clover Health certainly has the potential, but it carries more risks. Avoid CLOV stock at the current level.
Clover Stock’s Recovery Could Reverse in the Short-Term
With CLOV stock, a better entry point could emerge between now and its next earnings report.
Clover Health Is Risky But Offers a Healthy Upside Ahead
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock.
Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell
Clover's profitability metrics are improving but remain dismal, while the firm appears to lack strong, competitive advantages. As a result, CLOV stock is a sell.
Clover Health Is in Need of a Break After Massive Upsurge This Past Month
CLOV stock has seen positive momentum since its earnings release. Due to this, it may become a speculative investment again in the short run.
Clover Health Is in Dire Straits as Medical Costs Remain High
Clover Health’s medical loss ratio remains high. This means that the company is losing money per $1 of revenue it makes. CLOV stock upside could be limited.
Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022
CLOV stock is high-risk but potentially also high-reward as Clover Health rakes in the revenue and helps at-risk patients get healthcare.
What’s So Special About Clover Health?
As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology.
Sell Clover Health Stock in the Wake of Its Rally
CLOV stock recently enjoyed a considerable relief rally. However, its fundamentals remain as poor as ever and its gains will be fleeting.
Clover Health: Praying to the Great Google
Clover Health lacks the scale to succeed, although its Clover Assistant software is intriguing.
Is Clover Stock a Buy Right Now? Its 160% Revenue Growth Says Yes.
Off and on the price chart, CLOV stock is heading towards a better tomorrow and has much less to do with recent meme-driven news.
Why Is Clover Health (CLOV) Stock Up Today?
Clover Health is trading higher after director Chelsea Clinton disclosed a 100,000 share purchase. Who else is betting big on CLOV stock?
